Global Gastrointestinal Stromal Tumors Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Gastrointestinal Stromal Tumors Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumors Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumors Therapeutics market in any manner.
Global Gastrointestinal Stromal Tumors Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ascentage Pharma Group International
Bayer AG
Blueprint Medicines Corp
Bristol Myers Squibb Co.
Deciphera Pharmaceuticals Inc
Immunicum AB
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Xencor Inc.
Market Segmentation (by Type)
Oral
Non-oral
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumors Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Gastrointestinal Stromal Tumors Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumors Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumors Therapeutics market in any manner.
Global Gastrointestinal Stromal Tumors Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ascentage Pharma Group International
Bayer AG
Blueprint Medicines Corp
Bristol Myers Squibb Co.
Deciphera Pharmaceuticals Inc
Immunicum AB
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Xencor Inc.
Market Segmentation (by Type)
Oral
Non-oral
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Stromal Tumors Therapeutics Market
- Overview of the regional outlook of the Gastrointestinal Stromal Tumors Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumors Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumors Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumors Therapeutics Segment by Type
1.2.2 Gastrointestinal Stromal Tumors Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Stromal Tumors Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Stromal Tumors Therapeutics Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Stromal Tumors Therapeutics Market Competitive Situation and Trends
3.6.1 Gastrointestinal Stromal Tumors Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumors Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumors Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Stromal Tumors Therapeutics Price by Type (2019-2024)
7 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ascentage Pharma Group International
9.1.1 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.1.2 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.1.3 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.1.4 Ascentage Pharma Group International Business Overview
9.1.5 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
9.1.6 Ascentage Pharma Group International Recent Developments
9.2 Bayer AG
9.2.1 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.2.2 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.2.3 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.2.4 Bayer AG Business Overview
9.2.5 Bayer AG Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
9.2.6 Bayer AG Recent Developments
9.3 Blueprint Medicines Corp
9.3.1 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.3.2 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.3.3 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.3.4 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
9.3.5 Blueprint Medicines Corp Business Overview
9.3.6 Blueprint Medicines Corp Recent Developments
9.4 Bristol Myers Squibb Co.
9.4.1 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.4.2 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.4.3 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.4.4 Bristol Myers Squibb Co. Business Overview
9.4.5 Bristol Myers Squibb Co. Recent Developments
9.5 Deciphera Pharmaceuticals Inc
9.5.1 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.5.2 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.5.3 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.5.4 Deciphera Pharmaceuticals Inc Business Overview
9.5.5 Deciphera Pharmaceuticals Inc Recent Developments
9.6 Immunicum AB
9.6.1 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.6.2 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.6.3 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.6.4 Immunicum AB Business Overview
9.6.5 Immunicum AB Recent Developments
9.7 Novartis AG
9.7.1 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.7.2 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.7.3 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.7.4 Novartis AG Business Overview
9.7.5 Novartis AG Recent Developments
9.8 Pfizer Inc.
9.8.1 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.8.2 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.8.3 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.8.4 Pfizer Inc. Business Overview
9.8.5 Pfizer Inc. Recent Developments
9.9 Sun Pharmaceutical Industries Ltd
9.9.1 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.9.2 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.9.3 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.9.4 Sun Pharmaceutical Industries Ltd Business Overview
9.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
9.10 Xencor Inc.
9.10.1 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.10.2 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.10.3 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.10.4 Xencor Inc. Business Overview
9.10.5 Xencor Inc. Recent Developments
10 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast
10.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region
10.2.4 South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Stromal Tumors Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumors Therapeutics by Type (2025-2030)
11.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumors Therapeutics by Type (2025-2030)
11.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumors Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumors Therapeutics Segment by Type
1.2.2 Gastrointestinal Stromal Tumors Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Stromal Tumors Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Stromal Tumors Therapeutics Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Stromal Tumors Therapeutics Market Competitive Situation and Trends
3.6.1 Gastrointestinal Stromal Tumors Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumors Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumors Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Stromal Tumors Therapeutics Price by Type (2019-2024)
7 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ascentage Pharma Group International
9.1.1 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.1.2 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.1.3 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.1.4 Ascentage Pharma Group International Business Overview
9.1.5 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
9.1.6 Ascentage Pharma Group International Recent Developments
9.2 Bayer AG
9.2.1 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.2.2 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.2.3 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.2.4 Bayer AG Business Overview
9.2.5 Bayer AG Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
9.2.6 Bayer AG Recent Developments
9.3 Blueprint Medicines Corp
9.3.1 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.3.2 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.3.3 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.3.4 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
9.3.5 Blueprint Medicines Corp Business Overview
9.3.6 Blueprint Medicines Corp Recent Developments
9.4 Bristol Myers Squibb Co.
9.4.1 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.4.2 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.4.3 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.4.4 Bristol Myers Squibb Co. Business Overview
9.4.5 Bristol Myers Squibb Co. Recent Developments
9.5 Deciphera Pharmaceuticals Inc
9.5.1 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.5.2 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.5.3 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.5.4 Deciphera Pharmaceuticals Inc Business Overview
9.5.5 Deciphera Pharmaceuticals Inc Recent Developments
9.6 Immunicum AB
9.6.1 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.6.2 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.6.3 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.6.4 Immunicum AB Business Overview
9.6.5 Immunicum AB Recent Developments
9.7 Novartis AG
9.7.1 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.7.2 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.7.3 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.7.4 Novartis AG Business Overview
9.7.5 Novartis AG Recent Developments
9.8 Pfizer Inc.
9.8.1 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.8.2 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.8.3 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.8.4 Pfizer Inc. Business Overview
9.8.5 Pfizer Inc. Recent Developments
9.9 Sun Pharmaceutical Industries Ltd
9.9.1 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.9.2 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.9.3 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.9.4 Sun Pharmaceutical Industries Ltd Business Overview
9.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
9.10 Xencor Inc.
9.10.1 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
9.10.2 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
9.10.3 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
9.10.4 Xencor Inc. Business Overview
9.10.5 Xencor Inc. Recent Developments
10 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast
10.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region
10.2.4 South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Stromal Tumors Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumors Therapeutics by Type (2025-2030)
11.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumors Therapeutics by Type (2025-2030)
11.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumors Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Stromal Tumors Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumors Therapeutics as of 2022)
Table 10. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Stromal Tumors Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Stromal Tumors Therapeutics Product Type
Table 13. Global Gastrointestinal Stromal Tumors Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Stromal Tumors Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumors Therapeutics Market Challenges
Table 22. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Type (K Units)
Table 23. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (M USD)
Table 24. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Stromal Tumors Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Application
Table 30. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application
Table 31. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 44. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 45. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Ascentage Pharma Group International Business Overview
Table 47. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
Table 48. Ascentage Pharma Group International Recent Developments
Table 49. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 50. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 51. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
Table 54. Bayer AG Recent Developments
Table 55. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 56. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 57. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
Table 59. Blueprint Medicines Corp Business Overview
Table 60. Blueprint Medicines Corp Recent Developments
Table 61. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 62. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 63. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol Myers Squibb Co. Business Overview
Table 65. Bristol Myers Squibb Co. Recent Developments
Table 66. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 67. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 68. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Deciphera Pharmaceuticals Inc Business Overview
Table 70. Deciphera Pharmaceuticals Inc Recent Developments
Table 71. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 72. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 73. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Immunicum AB Business Overview
Table 75. Immunicum AB Recent Developments
Table 76. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 77. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 78. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Recent Developments
Table 81. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 82. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 83. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Recent Developments
Table 86. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 87. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 88. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Sun Pharmaceutical Industries Ltd Business Overview
Table 90. Sun Pharmaceutical Industries Ltd Recent Developments
Table 91. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 92. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 93. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Xencor Inc. Business Overview
Table 95. Xencor Inc. Recent Developments
Table 96. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Gastrointestinal Stromal Tumors Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumors Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Stromal Tumors Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumors Therapeutics as of 2022)
Table 10. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Stromal Tumors Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Stromal Tumors Therapeutics Product Type
Table 13. Global Gastrointestinal Stromal Tumors Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Stromal Tumors Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumors Therapeutics Market Challenges
Table 22. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Type (K Units)
Table 23. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (M USD)
Table 24. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Stromal Tumors Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Application
Table 30. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application
Table 31. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 44. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 45. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Ascentage Pharma Group International Business Overview
Table 47. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
Table 48. Ascentage Pharma Group International Recent Developments
Table 49. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 50. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 51. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
Table 54. Bayer AG Recent Developments
Table 55. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 56. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 57. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics SWOT Analysis
Table 59. Blueprint Medicines Corp Business Overview
Table 60. Blueprint Medicines Corp Recent Developments
Table 61. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 62. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 63. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol Myers Squibb Co. Business Overview
Table 65. Bristol Myers Squibb Co. Recent Developments
Table 66. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 67. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 68. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Deciphera Pharmaceuticals Inc Business Overview
Table 70. Deciphera Pharmaceuticals Inc Recent Developments
Table 71. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 72. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 73. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Immunicum AB Business Overview
Table 75. Immunicum AB Recent Developments
Table 76. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 77. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 78. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Recent Developments
Table 81. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 82. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 83. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Recent Developments
Table 86. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 87. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 88. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Sun Pharmaceutical Industries Ltd Business Overview
Table 90. Sun Pharmaceutical Industries Ltd Recent Developments
Table 91. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Basic Information
Table 92. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 93. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Xencor Inc. Business Overview
Table 95. Xencor Inc. Recent Developments
Table 96. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Gastrointestinal Stromal Tumors Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Stromal Tumors Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (M USD)
Figure 11. Gastrointestinal Stromal Tumors Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumors Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application
Figure 24. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application in 2023
Figure 28. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Stromal Tumors Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gastrointestinal Stromal Tumors Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (M USD)
Figure 11. Gastrointestinal Stromal Tumors Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumors Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application
Figure 24. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application in 2023
Figure 28. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Stromal Tumors Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Application (2025-2030)
